Preprint on discrimination against women reinstated by Elsevier server after removal for legal threats

Ann Lipton

A leading repository of social science which is owned by Elsevier has reposted an article it removed on New Year’s Day after the author was accused of defamation and the site was threatened with legal action if it didn’t remove the paper. 

The article in question was written by Ann Lipton, the associate dean for faculty research at Tulane University Law School and appeared on the Social Science Research Network (SSRN). 

Titled “Capital Discrimination,” the paper – which has been accepted by the Houston Law Review – explores:

Continue reading Preprint on discrimination against women reinstated by Elsevier server after removal for legal threats

Paper on “suspicious activities” on India-China border retracted

U.S. CIA

A journal has retracted a 2020 paper about looking for “suspicious activities” on the India-China border — including an incursion in which 20 Indian soldiers were reportedly killed – citing “legal reasons.”

The abstract in Springer Nature’s Journal of the Indian Society of Remote Sensing, which alleges that the soldiers were “brutally killed,” is rife with grammatical and punctuation errors: 

Continue reading Paper on “suspicious activities” on India-China border retracted

Court injunction forces gastro journal to slap expressions of concern on 40 articles about probiotics

A gastroenterology journal has issued expressions of concern for forty articles about a probiotic formulation that has been at the center of a long-running legal saga in the United States and Europe.  

The articles appeared in the Journal of Crohn’s and Colitis, the official journal of the European Crohn’s and Colitis Organisation (ECCO) and date back to 2007. All mention a proprietary formulation of probiotics – and therein lies the tale.

Continue reading Court injunction forces gastro journal to slap expressions of concern on 40 articles about probiotics

‘A clusterf**K’: Authors plagiarize material from NIH and elsewhere, make legal threats — then see their paper retracted

“clusterfuck,” by J E Theriot, via CC BY 2.0 license

Stolen data, “gross” misconduct, a strange game of scientific telephone, and accusations of intimidation – Santa came late to Retraction Watch but he delivered the goods in style.

Last May, the journal Cureus published a paper titled “Idiopathic CD4+ Lymphocytopenia Due to Homozygous Loss of the CD4 Start Codon.” The paper caught the notice of Andrea Lisco, a researcher at the National Institutes of Health’s Clinical Center, who earlier this month was looking for his own article in the Journal of Infectious Diseases on the same topic. Lisco told us: 

I did accidentally run in the Cureus paper while I was looking for my original publication on JID and I did report it immediately to Cureus and JID editorial offices.

The journal acted with what we’d consider to be remarkable haste. Within a few weeks came the following retraction notice

Continue reading ‘A clusterf**K’: Authors plagiarize material from NIH and elsewhere, make legal threats — then see their paper retracted

Court tosses $50 billion suit by ‘prince of panspermia’ against Springer Nature

A neuroscientist once called the “prince of panspermia” has lost a lawsuit against Springer Nature stemming from a 2019 paper of his that a journal retracted.

Here’s the summary from United States District Judge John P. Cronan, who heard the original case:

Continue reading Court tosses $50 billion suit by ‘prince of panspermia’ against Springer Nature

Stanford prof fights efforts to make him pay at least $75,000 in legal fees after dropping defamation suit

Mark Jacobson

A Stanford University professor who tried to sue a critic and the journal that published an unfavorable view of his work is opposing a judge’s order that he pay $75,000 in legal fees generated in the case. 

In 2017, Mark Jacobson, an engineer who studies energy at the California institution, sued Christopher Clack and the Proceedings of the National Academy of Sciences (PNAS) after the journal published an article which cast doubt on some of the conclusions in a 2015 paper Jacobson had written in PNAS. The amount of the defamation claim? $10 million from each of the two parties, plus punitive damages and “any and all relief.” 

Jacobson withdrew his lawsuit, which also demanded a retraction, in 2018, at which point Clack and the journal fired back. They filed their own suit grounded in the anti-SLAPP — short for “Strategic Lawsuit Against Public Participation” — statute, in which they asked for Jacobson to pay their legal fees.

Continue reading Stanford prof fights efforts to make him pay at least $75,000 in legal fees after dropping defamation suit

Former Tufts grad student settles lawsuit alleging retaliation for whistleblowing

A former veterinary student at Tufts University has settled a $1 million lawsuit alleging that she was punished for claiming that her mentor at the school falsified data in a 2014 article. 

In 2019, Kristy Meadows sued Tufts and two faculty members, Elizabeth Byrnes and Dean Joyce Knoll, whom she said retaliated against her for claiming that Byrnes cooked her results in an article Meadows and Byrnes published in Neuroscience titled “Sex- and age-specific differences in relaxin family peptide receptor expression within the hippocampus and amygdala in rats.” 

According to Law360, which first reported on the settlement

Continue reading Former Tufts grad student settles lawsuit alleging retaliation for whistleblowing

Critics face legal threats as journal takes more than three years to act

Ben Mol

More than three and a half years after being alerted to concerns about the data in a 2015 article, an obstetrics journal has finally retracted the paper, citing a lack of ethics approval for the work. Meanwhile, the co-author of a meta-analysis that relies heavily on the paper has suggested that some critics of the underlying work risk legal action for their efforts.

The study, “Vaginal progesterone for prevention of preterm labor in asymptomatic twin pregnancies with sonographic short cervix: a randomized clinical trial of efficacy and safety,” appeared in Archives of Gynecology and Obstetrics (AGO) and was conducted by Waleed El-refaie, Mohamed S. Abdelhafez and Ahmed Badawy, of the University of Mansoura in Egypt. The article has been cited 29 times, according to Clarivate Analytics’ Web of Science.

As we reported last October, data sleuths have accused Badawy and some of his colleagues at Mansoura of having fabricated data and other misconduct in some 250 clinical trials — charges which were (and may still be) apparently convincing enough to warrant a university inquiry. 

Continue reading Critics face legal threats as journal takes more than three years to act

A scientist critic was sued, and won — but did not emerge unscathed. This is his story.

David Sanders

Retraction Watch readers may be familiar with the name David Sanders. Sanders, a biologist at Purdue University, has become a scientific sleuth, ferreting out problems in numerous papers. In one of those cases, that of Ohio State University professor Carlo Croce, Sanders ended up being sued — before an article in which he was quoted even came out. He eventually prevailed, but the episode left a mark, as readers will learn in this Q&A. (It has left a mark on Croce, too, in the form of 10 retractions and two suits brought by teams of lawyers for unpaid bills.)

Retraction Watch (RW): Carlo Croce sued you in 2017. Why?

Continue reading A scientist critic was sued, and won — but did not emerge unscathed. This is his story.

Pharma company demands retraction, damages in lawsuit against journal

A drug company that manufactures a painkiller used for surgery patients has sued an anesthesiology journal along with its editor and publisher and the authors of articles that it says denigrated its product unfairly.

In a complaint filed yesterday in U.S. District Court in New Jersey, Pacira Biosciences claims that “In the February 2021 issue of Anesthesiology, the ASA, reflecting a bias against EXPAREL amongst the editorial staff at Anesthesiology, published three articles, and other related content, that seriously disparage Pacira’s product EXPAREL,” an FDA-approved drug which they say is “a non-opioid pain medication proven to prolong post-surgery pain relief.” 

In seeking retractions, compensatory and punitive damages exceeding $75,000 — the threshold for U.S. federal court — and lawyers’ fees, the company’s attorneys at Latham & Watkins write:

Continue reading Pharma company demands retraction, damages in lawsuit against journal